Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Mutational Profiling Predicts Clinical Outcomes to Azacytidine and Low Dose Cytarabine Plus Fludarabine (FLUGA) in Elderly Acute Myeloid Leukemia Patients Enrolled in the Pethema Phase III Flugaza Trial

Blood (2019) 134 (Supplement_1): 3891.

https://doi.org/10.1182/blood-2019-127187

Published: 2019

Journal Articles

The Role of SMAD7 Downstream of TEL-AML1 Signalling in t(12;21) Acute Lymphoblastic Leukemia

Aishwarya Sundaresh, Miss, Maurizio Mangolini, Dr, Jasper de Boer, Dr, Mike Hubank, Dr, Nicholas Goulden, Dr, Owen Williams, PhD

Blood (2015) 126 (23): 4823.

https://doi.org/10.1182/blood.V126.23.4823.4823

Published: 2015

Journal Articles

Molecular and Genetic Characterization of Fit, Elderly Patients Receiving Oral Fludarabine, Oral Cyclophosphamide and Intravenous Rituximab (OFOCIR) As Initial Treatment of Chronic Lymphocytic Leukemia (CLL)

Xavier C Badoux, MB BS, Giles Best, BSc (Hons), PhD, Sara Gabrielli, Miss, Melanie Hayes, PhD, Ying Zhu, PhD, Stephen Mulligan, MBBS, MD FRACP, FRCPA, Bryone J Kuss, MBBS, PhD FRCPA, FRACP

Blood (2014) 124 (21): 1959.

https://doi.org/10.1182/blood.V124.21.1959.1959

Published: 2014

Journal Articles

Genomic Profiling In Fit, Elderly Patients Receiving Oral Fludarabine, Oral Cyclophosphamide and Intravenous Rituximab (ALLG CLL5 OFOCIR trial) As Initial Treatment Of Chronic Lymphocytic Leukemia (CLL)

XAVIER BADOUX, MBBS FRACP FRCPA, Giles Best, BSc (Hons) Ph.D., Sara Gabrielli, Miss, Ying Zhu, PhD, Melanie Hayes, PhD, Bryone J Kuss, MBBS, PhD, FRCPA, William Stevenson, MBBS, PhD, Stephen P Mulligan, MBBS, PhD, FRACP, FRCPA

Blood (2013) 122 (21): 1624.

https://doi.org/10.1182/blood.V122.21.1624.1624

Published: 2013

Journal Articles

NOTCH1 , SF3B1 and BIRC3 Mutations in Chronic Lymphocytic Leukemia (CLL) Patients Requiring First-LINE Treatment: Correlation with Biological Parameters and Response to Treatment

Sabina Chiaretti, MD, PhD, Marilisa Marinelli, PhD, Ilaria Del Giudice, MD, PhD, Silvia Bonina, PhD student, Sara Gabrielli, Miss, Alfonso Piciocchi, Monica Messina, PhD, Marco Vignetti, MD, Davide Rossi, MD, PhD, Valeria Di Maio, Miss, Francesca Romana Mauro, MD, Anna Guarini, PhD, Gianluca Gaidano, MD, PhD, Robin Foà, MD

Blood (2012) 120 (21): 1784.

https://doi.org/10.1182/blood.V120.21.1784.1784

Published: 2012

Journal Articles

Myeloperoxidase-Derived Halogenative Stress, a Possible Cause of Benzene Leukemogenesis

Takuro Nishikawa, MD, Emiko Miyahara, Miss, Masahisa Horiuchi, MD, Kimiko Izumo, Miss, Yasuhiro Okamoto, MD, Yoshichika Kawai, PhD, Yoshifumi Kawano, MD, PhD, Toru Takeuchi, MD, PhD

Blood (2011) 118 (21): 4404.

https://doi.org/10.1182/blood.V118.21.4404.4404

Published: 2011

Journal Articles

At-Home Management of Aplastic Phase Following High-Dose Melphalan and Autologous Haematopoietic Stem Cell Transplantation for Multiple Myeloma Patients: A Pilot Study

Massimo Martino, MD, Grazia Pellicano’, MD, Tiziana Moscato, MD, Elisabetta Massara, MD, Roberta Fedele, MD, Giuseppe Console, MD, Letteria Russo, Miss, Giuseppe Messina, MD, Rosalba Di Filippo Scali, Giuseppe Irrera, MD

Blood (2011) 118 (21): 4497.

https://doi.org/10.1182/blood.V118.21.4497.4497

Published: 2011

Journal Articles

IgV H Germline and Mutated Chronic Lymphocytic Leukemia (CLL) Cases Exert a Diverse Responsiveness upon BCR Ligation.

Simona Tavolaro, BS, Roberta Maggio, BS, Nadia Peragine, BS, Monica Messina, BS, Franca Citarella, PhD, Simona Santangelo Miss, Marilisa Marinelli, BS, Maria R. Ricciardi, PhD, Maria S. De Propris, PhD, Ilaria Del Giudice, MD, PhD, Francesca R. Mauro, MD, Sabina Chiaretti, MD, PhD, Robert Foa, MD, Anna Guarini, PhD

Blood (2007) 110 (11): 1133.

https://doi.org/10.1182/blood.V110.11.1133.1133

Published: 2007

Journal Articles

Gene Expression Profile of Protein Kinases Reveals a Distinctive Signature of Chronic Lymphocytic Leukemia (CLL) and Points to a Role of Second Generation Protein Kinase Inhibitors.

Simona Tavolaro, BS, Sabina Chiaretti, MD, PhD, Monica Messina, BS, Francesca R. Mauro, MD, Ilaria Del Giudice, MD PhD, Roberta Maggio, BS, Emanuela M. Ghia, BS, Marilisa Marinelli, BS, Simona Santangelo Miss, Anna Guarini, PhD, Robert Foa, MD

Blood (2006) 108 (11): 2794.

https://doi.org/10.1182/blood.V108.11.2794.2794

Published: 2006

Journal Articles

Protein Kinase Gene Expression Profile in Adult Acute Lymphocytic Leukemia (ALL): Identification of Novel Therapeutic Targets.

Monica Messina, BS, Sabina Chiaretti, MD, PhD, Simona Tavolaro, BS, Irene Della Starza Miss, Antonella Vitale, MD, Cristina Ariola, BS, Alina Negulici Miss, Loredana Elia, PhD, Anna Guarini, PhD, Robert Foa, MD

Blood (2006) 108 (11): 1824.

https://doi.org/10.1182/blood.V108.11.1824.1824

Published: 2006

Journal Articles

Histopathologic and Molecular Features of Persistent Polyclonal B-Cell Lymphocytosis Challenging the Benign Nature of the Disorder.

Ilaria Del Giudice, MD, PhD, Stefano A. Pileri, MD, Maura Rossi, BTD, Elena Sabattini, MD, Cristina Campidelli, MD, Irene Della Starza Miss, Stefania M. De Propris, PhD, Francesca Mancini, PhD, Francesca R. Mauro, MD, Agostino Tafuri, MD, Luisa Bizzoni, MD, Angela Rago, MD, Angela Amendola, MD, Anna Guarini, PhD, Robert Foa, MD

Blood (2006) 108 (11): 4612.

https://doi.org/10.1182/blood.V108.11.4612.4612

Published: 2006

Journal Articles

The MicroRNA (miR) Profile in B-Cell Chronic Lymphocytic Leukemia (CLL) Reveals a Differential Expression of miR-21, miR-155 and miR-150 between Leukemic and Normal B Lymphocytes, and of miR-150, miR-29bc and miR-223 between IgV H Mutated and Unmutated Patients.

Sabina Chiaretti, MD, PhD, Valerio Fulci, PhD, Marina Goldoni, BS, Gianluca Azzalin, Mr, Simona Tavolaro, BS, Monica Messina, BS, Roberta Maggio, BS, Nadia Peragine, BS, Simona Santangelo Miss, Francesca R. Mauro, MD, Anna Guarini, PhD, Giuseppe Macino, PhD, Robert Foa, MD

Blood (2006) 108 (11): 298.

https://doi.org/10.1182/blood.V108.11.298.298

Published: 2006

Journal Articles

Platelet Functional Defects in Thrombocytopenic Purpura

J. A. BONNIN, MISS MAUREEN JENNER

Blood (1957) 12 (8): 726–732.

https://doi.org/10.1182/blood.V12.8.726.726

Published: 1957

Journal Articles

Studies on Thrombopoiesis : II. Thrombocytopoiesis in Vitro from the Bone Marrow of Patients with Idiopathic Thrombocytopenic Purpura

G. IZAK, D. NELKEN, MISS A. HERZOG

Blood (1957) 12 (6): 520–528.

https://doi.org/10.1182/blood.V12.6.520.520

Published: 1957

Journal Articles

Studies on Thrombopoiesis : I. Thrombocytopoiesis in Vitro: Experiments with Animal and Normal Human Material

G. IZAK, D. NELKEN, J. GUREVITCH, MISS A. HERZOG

Blood (1957) 12 (6): 507–519.

https://doi.org/10.1182/blood.V12.6.507.507

Published: 1957

Journal Articles

A NOTE ON THE EFFECTIVENESS OF VITAMIN B 12 IN THE TREATMENT OF TROPICAL SPRUE IN RELAPSE

RAMON M. SUAREZ, M.D., TOM D. SPIES, M.D., F. HERNANDEZ-MORALES, M.D., ENRIQUE PEREZ, M.D., MISS CLEMENCIA BENITEZ-GAUTIER

Blood (1949) 4 (10): 1124–1130.

https://doi.org/10.1182/blood.V4.10.1124.1124

Published: 1949

Journal Articles

INTERRELATIONSHIP BETWEEN THE Rh SYSTEM AND THE A B SYSTEM

ERNEST WITEBSKY, M.D., MRS. LIVIA BLUM, MISS DORIS HOWLES, MISS HELEN WARD

Blood (1948) 3 (Special_Issue_Number_2): 66–79.

https://doi.org/10.1182/blood.V3.Special_Issue_Number_2.66.66

Published: 1948

NARROW

Mutational Profiling Predicts Clinical Outcomes to Azacytidine and Low Dose Cytarabine Plus Fludarabine (FLUGA) in Elderly Acute Myeloid Leukemia Patients Enrolled in the Pethema Phase III Flugaza Trial

The Role of SMAD7 Downstream of TEL-AML1 Signalling in t(12;21) Acute Lymphoblastic Leukemia

Molecular and Genetic Characterization of Fit, Elderly Patients Receiving Oral Fludarabine, Oral Cyclophosphamide and Intravenous Rituximab (OFOCIR) As Initial Treatment of Chronic Lymphocytic Leukemia (CLL)

Genomic Profiling In Fit, Elderly Patients Receiving Oral Fludarabine, Oral Cyclophosphamide and Intravenous Rituximab (ALLG CLL5 OFOCIR trial) As Initial Treatment Of Chronic Lymphocytic Leukemia (CLL)

NOTCH1 , SF3B1 and BIRC3 Mutations in Chronic Lymphocytic Leukemia (CLL) Patients Requiring First-LINE Treatment: Correlation with Biological Parameters and Response to Treatment

Myeloperoxidase-Derived Halogenative Stress, a Possible Cause of Benzene Leukemogenesis

At-Home Management of Aplastic Phase Following High-Dose Melphalan and Autologous Haematopoietic Stem Cell Transplantation for Multiple Myeloma Patients: A Pilot Study

IgV H Germline and Mutated Chronic Lymphocytic Leukemia (CLL) Cases Exert a Diverse Responsiveness upon BCR Ligation.

Gene Expression Profile of Protein Kinases Reveals a Distinctive Signature of Chronic Lymphocytic Leukemia (CLL) and Points to a Role of Second Generation Protein Kinase Inhibitors.

Protein Kinase Gene Expression Profile in Adult Acute Lymphocytic Leukemia (ALL): Identification of Novel Therapeutic Targets.

Histopathologic and Molecular Features of Persistent Polyclonal B-Cell Lymphocytosis Challenging the Benign Nature of the Disorder.

The MicroRNA (miR) Profile in B-Cell Chronic Lymphocytic Leukemia (CLL) Reveals a Differential Expression of miR-21, miR-155 and miR-150 between Leukemic and Normal B Lymphocytes, and of miR-150, miR-29bc and miR-223 between IgV H Mutated and Unmutated Patients.

Platelet Functional Defects in Thrombocytopenic Purpura

Studies on Thrombopoiesis : II. Thrombocytopoiesis in Vitro from the Bone Marrow of Patients with Idiopathic Thrombocytopenic Purpura

Studies on Thrombopoiesis : I. Thrombocytopoiesis in Vitro: Experiments with Animal and Normal Human Material

A NOTE ON THE EFFECTIVENESS OF VITAMIN B 12 IN THE TREATMENT OF TROPICAL SPRUE IN RELAPSE

INTERRELATIONSHIP BETWEEN THE Rh SYSTEM AND THE A B SYSTEM

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only